Drug Profile
SSH 14
Latest Information Update: 05 Nov 2002
Price :
$50
*
At a glance
- Originator Iketon Farmaceutici
- Developer Nonindustrial source
- Class Anticoagulants; Antithrombotics; Low molecular weight heparins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 28 Mar 2000 Investigation in Thrombosis in France (Unknown route)
- 28 Mar 2000 Investigation in Thrombosis in Germany (Unknown route)
- 28 Mar 2000 Investigation in Thrombosis in USA (Unknown route)